Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

PURPOSE: To evaluate the efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis (nr-axSpA). METHODS: Patients fulfilled Assessment of Spondyloarthritis international Society (ASAS) criteria for axial spondyloarthritis, had a Bath Ankylosing Spondylitis Disease Ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieper, Joachim, van der Heijde, Désirée, Dougados, Maxime, Mease, Philip J, Maksymowych, Walter P, Brown, Matthew A, Arora, Vipin, Pangan, Aileen L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2013
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664374/
https://www.ncbi.nlm.nih.gov/pubmed/22772328
http://dx.doi.org/10.1136/annrheumdis-2012-201766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664374/
https://www.ncbi.nlm.nih.gov/pubmed/22772328
http://dx.doi.org/10.1136/annrheumdis-2012-201766

Ejemplares similares